Clinical Trials Browser

Phase 2 × Recurrence × belantamab mafodotin × Clear all

NCT05922501 2026-01-14

ISABELA

Phase 2 Recruiting

Multiple Myeloma, Recurrence

NCT05064358 2025-10-07

DREAMM 14

Phase 2 Active not recruiting

177 enrolled 37 charts

Multiple Myeloma, Recurrence